This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Bimatoprost
LATISSE, LUMGAN, LUMIGAN PF, LUMIGAN RC – Allergan Inc. (NOC Search)
Patents:
- 2144967: APOTEX, TEVA
- 2475106: SANDOZ
- 2585691: MYLAN, TEVA, COBALT, , APOTEX
Unknown/Other
- PM(NOC) – A-14-24 – T-1994-21 (2023 FC 1686)
ACTAVIS
- PM(NOC) – A-321-14
APOTEX
- PM(NOC) – A-299-14 (2015 FCA 137) – T-1151-12 (2014 FC 567, 2013 FC 1165)
COBALT
- PM(NOC) – T-1125-12 (2014 FC 566)
MYLAN
- PM(NOC) – T-18-13
SANDOZ
- PM(NOC) – T-2068-15
TEVA
- PM(NOC) – T-360-13
Return to the Patented Medicine Litigation page.